Lizard Envenomation Medication

  • Author: Robert L Norris, MD; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Dec 14, 2011
 

Medication Summary

No specific agents are used to treat lizard envenomations. Although 2 experimental antivenoms have been produced for the Gila monster, neither has been made commercially available. Drug therapy is entirely symptomatic (eg, local anesthetics, analgesics, antiemetics). If antibiotics are administered, they should be broad-spectrum and they should provide coverage for gram-negative organisms. For the rare case of anaphylaxis/angioedema, therapy should be instituted with sympathomimetic agents, antihistamines, and/or steroids.

Next

Cardiovascular Agents

Class Summary

Possess alpha- and beta-adrenergic effects that are useful in reversing anaphylactic reactions (eg, angioedema, bronchospasm, hypotension).

Epinephrine (Adrenalin, EpiPen)

 

DOC for the treatment of anaphylactoid reactions. Alpha-agonist effects increase peripheral vascular resistance and reverse peripheral vasodilatation and vascular permeability, thus helping to restore vascular tone and blood pressure. The beta-agonist effects increase heart rate and inotropism and cause bronchodilatation

Previous
Next

Corticosteroids

Class Summary

Onset of action is approximately 4-6 h, although some synergistic activity may be noted when simultaneously used with sympathomimetic agents. Steroids may be needed in the rare event of an allergic reaction to lizard venom. Corticosteroids have no role in the management of envenomation itself.

Methylprednisolone (Solu-Medrol)

 

Decreases inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing increased capillary permeability

Prednisone (Deltasone, Orasone, Meticorten)

 

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability.

Previous
Next

Antihistamines

Class Summary

Prevent the histamine response in sensory nerve endings and blood vessels. More effective in preventing histamine response than in reversing it.

Diphenhydramine (Benadryl, Benylin, Bydramine)

 

Used for the symptomatic relief of allergic symptoms caused by histamine released in response to allergens.

Cimetidine (Tagamet)

 

An H2 antagonist that, when combined with an H1 type, may be useful in treating itching and flushing in anaphylaxis, pruritus, urticaria, and contact dermatitis that do not respond to H1-receptor antagonists alone. Use in addition to H1 antihistamines.

Previous
Next

Local anesthetics

Class Summary

Local anesthetics can be injected, either locally or regionally, to aid in exploration of wounds (to rule out damage to underlying structures or retained teeth).

Lidocaine anesthetic

 

Amide local anesthetic used in 1-2% concentration. Inhibits depolarization of type C sensory neurons by blocking sodium channels. Epinephrine should be avoided in venomous lizard bites to prevent causing additional local tissue ischemia.

Previous
Next

Analgesics

Class Summary

Patients may require narcotic analgesics for pain control after venomous lizard bites. In choosing a narcotic analgesic, to prevent worsening venom effects, it is best to select a narcotic that has less tendency to induce histamine release, such as fentanyl.

Fentanyl citrate (Sublimaze)

 

A synthetic opioid that is 75-200 times more potent and much shorter half-life than morphine sulfate. Has less hypotensive effects and is safer in patients with hyperactive airway disease than morphine because of minimal-to-no associated histamine release. By itself, it causes little cardiovascular compromise, although addition of benzodiazepines or other sedatives may result in decreased cardiac output and blood pressure.

Highly lipophilic and protein-bound. Prolonged exposure leads to accumulation in fat and delays weaning process.

Consider continuous infusion because of the short half-life of fentanyl. Parenteral form is DOC for conscious sedation analgesia. Ideal for analgesic action of short duration during anesthesia and immediate postoperative period.

Excellent choice for pain management and sedation with short duration (30-60 min) and easy to titrate. Easily and quickly reversed by naloxone.

After initial parenteral dose, subsequent parenteral doses should not be titrated more frequently than q3h or q6h thereafter.

Transdermal form is used only for chronic pain conditions in opioid-tolerant patients. When using transdermal dosage form, majority of patients are controlled with 72-h dosing intervals; however, some patients require dosing intervals of 48 h.

Easily and quickly reversed by naloxone.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Robert L Norris, MD  Professor, Department of Surgery, Chief, Division of Emergency Medicine, Stanford University Medical Center

Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Mark S Slabinski, MD, FACEP, FAAEM  Vice President, EMP Medical Group

Mark S Slabinski, MD, FACEP, FAAEM is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Ohio State Medical Association

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

A Antoine Kazzi  MD, Deputy Chief of Staff, American University of Beirut Medical Center; Associate Professor, Department of Emergency Medicine, American University of Beirut, Lebanon

A Antoine Kazzi is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

References
  1. Mebs D. Clinical toxicology of Helodermatidae lizard bites. In: Handbook of Clinical Toxicology of Animal Venoms and Poisons. 1995: 361-366.

  2. Piacentine J, Curry SC, Ryan PJ. Life-threatening anaphylaxis following gila monster bite. Ann Emer Med. 1986;15:959-961. [Medline].

  3. Bou-Abboud CF, Kardassakis DG. Acute myocardial infarction following a Gila monster (Heloderma suspectum cinctum) bite. West J Med. 1988;148(5):577-579. [Medline].

  4. Preston CA. Hypotension, myocardial infarction, an coagulopathy following gila monster bite. J Emer Med. 1989;7:37-40. [Medline].

  5. Brown DE, Carmony NB. Gila Monster: Facts and Folklore of America's Aztec Lizard. 1991;1-126.

  6. Cantrell FL. Envenomation by the Mexican beaded lizard: a case report. J Toxicol Clin Toxicol. 2003;41(3):241-4. [Medline].

  7. Hooker KR, Caravati EM. Gila monster envenomation. Ann Emerg Med. 1994;24(4):731-735. [Medline].

  8. Kunkel DB. Bites of venomous reptiles. Emerg Med Clin North Am. Aug 1984;2(3):563-77. [Medline].

  9. Kunkel DB, Curry SC, Vance MV, Ryan PJ. Reptile envenomations. J Toxicol Clin Toxicol. 1983-84;21(4-5):503-26. [Medline].

  10. McNally J, Boesen K, Boyer L. Toxicologic information resources for reptile envenomations. Vet Clin North Am Exot Anim Pract. May 2008;11(2):389-401, viii. [Medline].

  11. Miller MF. Gila monster envenomation. Ann Emerg Med. May 1995;25(5):720. [Medline].

  12. Russell FE. Snake Venom Poisoning. Scholium International, Inc;1983:1-562.

  13. Stahnke HL, Heffron WA, Lewis DL. Bite of the Gila monster. Rocky Mt Med J. Sep 1970;67(9):25-30. [Medline].

  14. Streiffer RH. Bite of the venomous lizard, the Gila monster. Postgrad Med. Feb 1 1986;79(2):297-9, 302. [Medline].

  15. Strimple PD, Tomassoni AJ, Otten EJ. Report on envenomation by a Gila monster (Heloderma suspectum) with a discussion of venom apparatus, clinical findings, and treatment. Wilderness Environ Med. May 1997;8(2):111-6. [Medline].

Previous
Next
 
A Gila monster (Heloderma suspectum). Photo by Holly McNally.
Close-up of the head of a Gila monster. Clearly evident is the bulging musculature of the jaws, which gives this animal a tenacious bite. Photo by Holly McNally.
The dentition of a Gila monster. The grooved surfaces of the teeth are evident. These grooves allow for venom movement from the venom glands into the victim's tissues. Photo by Michael Cardwell.
A Gila monster (Heloderma suspectum). Photo by Michael Cardwell.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.